NABI
12Patents
0Active
12Granted
30Portfolio score
Filing activity: Dec 22, 1994 → Sep 24, 2001
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6294177A | Staphylococcus aureus antigen-containing whole cell vaccine | Human Necessities | 49 | Expired |
| US6232082A | Hapten-carrier conjugates for treating and preventing nicotine addiction | Emerging Cross-Sectional Technologies | 42 | Expired |
| US5770208A | Staphylococcus aureus B-linked hexosamine antigen | Emerging Cross-Sectional Technologies | 40 | Expired |
| US5866140A | Type I surface antigen associated with staphylococcus epidermidis | Human Necessities | 25 | Expired |
| US5843912A | Ring-expanded nucleosides and nucleotides | Chemistry; Metallurgy | 19 | Expired |
| US6756361B1 | Enterococcus antigens and vaccines | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6355625B1 | Compositions of &bgr;-glucans and specific IGIV | Human Necessities | 14 | Expired |
| US6518031B2 | Hapten-carrier conjugates for treating and preventing nicotine addiction | Emerging Cross-Sectional Technologies | 8 | Expired |
| US6194161A | Staphylococcus aureus antigen | Emerging Cross-Sectional Technologies | 8 | Expired |
| US5961975A | Type I surface antigen associated with staphylococcus epidermidis | Human Necessities | 8 | Expired |
| US6537559B2 | Staphylococcus aureus antigen-containing whole cell vaccine | Human Necessities | 1 | Expired |
| US6677310B1 | Ring-expanded nucleosides and nucleotides | Human Necessities | 0 | Expired |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.